Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Treating epileptic emerge… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Treating epileptic emergencies - pharmacological advances

Artikel i vetenskaplig tidskrift
Författare Johan Zelano
Elinor Ben-Menachem
Publicerad i Expert Opinion on Pharmacotherapy
Volym 17
Nummer/häfte 16
Sidor 2227-2234
ISSN 1465-6566
Publiceringsår 2016
Publicerad vid Institutionen för neurovetenskap och fysiologi
Sidor 2227-2234
Språk en
Länkar dx.doi.org/10.1080/14656566.2016.12...
Ämnesord Status epilepticus, epileptic emergency, side effects of anti-seizure drugs, seizure clusters, convulsive status epilepticus, acute repetitive seizures, antiepileptic, drugs, intravenous valproate, refractory epilepsy, double-blind, levetiracetam, phenytoin, lacosamide, safety, Pharmacology & Pharmacy
Ämneskategorier Farmakologi, Klinisk farmakologi

Sammanfattning

Introduction: Epileptic emergencies are frequently encountered and include ictal events as status epilepticus or seizure clusters, and non-ictal situations like postictal psychosis or acute drug side effects. The aim of this review was to describe recent pharmacological advances in the treatment of epileptic emergencies.Areas covered: Based on clinically relevant questions, a literature search was performed. The search showed that most pharmacological advances have been made in management of status epilepticus, where substantial literature has accumulated on several AEDs with potentially less side-effects than the traditional choices. The use of these drugs; valproate, levetiracetam, and lacosamide, was therefore made the main focus of this review. Pharmacological advances in treatment of other epileptic emergencies were scarce, and were therefore covered more briefly in the Expert Opinion section.Expert opinion: This section outlines our current practice in management of status epilepticus and seizures clusters. Our opinion is that valproate is an equal alternative as second line treatment to fosphenytoin, with levetiracetam considered a good choice in frail and elderly patients. Due to the lack of literature, lacosamide is used mainly as a 2(nd) line drug after the failure of valproate, fosphenytoin and levetiracetam. Our review underlines the need for more research in management of epileptic emergencies.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?